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Morphine- and ethanol-induced stimulation of neuronal firing of ventral tegmental
area (VTA) dopaminergic neurons and of dopamine (DA) transmission in the shell
of the nucleus accumbens (AcbSh) represents a crucial electrophysiological and
neurochemical response underlying the ability of these compounds to elicit motivated
behaviors and trigger a cascade of plasticity-related biochemical events. Previous
studies indicate that the standardized methanolic extract of Withania somnifera roots
(WSE) prevents morphine- and ethanol-elicited conditioned place preference and oral
ethanol self-administration. Aim of the present research was to investigate whether
WSE may also interfere with the ability of morphine and ethanol to stimulate VTA
dopaminergic neurons and thus AcbSh DA transmission as assessed in male Sprague-
Dawley rats by means of patch-clamp recordings in mesencephalic slices and
in vivo brain microdialysis, respectively. Morphine and ethanol significantly stimulated
spontaneous firing rate of VTA neurons and DA transmission in the AcbSh. WSE, at
concentrations (200–400 µg/ml) that significantly reduce spontaneous neuronal firing
of VTA DA neurons via a GABAA- but not GABAB-mediated mechanism, suppressed
the stimulatory actions of both morphine and ethanol. Moreover, in vivo administration
of WSE at a dose (75 mg/kg) that fails to affect basal DA transmission, significantly
prevented both morphine- and ethanol-elicited increases of DA in the AcbSh. Overall,
these results highlight the ability of WSE to interfere with morphine- and ethanol-
mediated central effects and suggest a mechanistic interpretation of the efficacy of this
extract to prevent the motivational properties of these compounds.
Keywords: dopamine, ethanol, morphine, nucleus accumbens shell, standardized Withania somnifera extract,
ventral tegmental area, GABA
INTRODUCTION
Withania somnifera (WS) Dunal (family Solanaceae), also known as Ashwagandha or Indian
Ginseng, is a plant widely used in traditional Ayurvedic medicine in India since antiquity (Kulkarni
and Dhir, 2008). It is included in the Indian Pharmacopoeia (Singh et al., 2011) as a safe official
medication for the treatment of several ailments (Dar et al., 2016) and recent evidence supports its
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anti-inflammatory, immunomodulatory, neuroprotective
(Bhatnagar et al., 1975; Kulkarni et al., 2008; Dar et al., 2016;
Yenisetti et al., 2016) and free-radical scavenging (Bhattacharya
et al., 2001; Davis and Kuttan, 2001; Prakash et al., 2014; Dar
et al., 2015) properties. Moreover, WS has been shown to
modulate GABAergic [(γ-amino-butyric acid (GABA)] (Mehta
et al., 1991; Kulkarni and Dhir, 2008) and cholinergic (Schliebs
et al., 1997) neurotransmission and to affect different properties
of addictive drugs. In fact, several studies have reported that
WS prevents the development of tolerance and dependence
to morphine (Kulkarni and Ninan, 1997) as well as morphine
withdrawal-dependent reduction of dendritic spine density in
the shell of the nucleus accumbens (AcbSh) (Diana et al., 2006;
Kasture et al., 2009). In addition, WS has also been shown to
reduce anxiety associated with ethanol-withdrawal and increase
ethanol-induced anxiolysis (Gupta and Rana, 2008).
Drug addiction is defined as the progressive loss of
control over drug taking and results from a long series of
neuroadaptations taking place in selective neural circuits in
response to the progressive exposure to addictive drugs (Volkow
and Morales, 2015). Notably, among these drugs both morphine
(Di Chiara and Imperato, 1988) and ethanol (Imperato and
Di Chiara, 1986; Bassareo et al., 2003) preferentially increase
dopamine (DA) transmission in the AcbSh, a property that
has been pinpointed as a neurochemical feature shared by
all substances with addictive potential (Di Chiara, 1999; Di
Chiara et al., 2004). Moreover, this property represents the
neurophysiological correlate of increased spontaneous firing
rate of DA neurons in the ventral tegmental area (VTA) by
addictive drugs, including morphine (Jalabert et al., 2011; Chen
et al., 2015) and ethanol (Gessa et al., 1985; Brodie et al.,
1990; Brodie and Appel, 1998; Xiao and Ye, 2008; Theile
et al., 2011) on the one hand, and of morphine- and ethanol-
mediated motivated behaviors (Di Chiara, 1999; Di Chiara et al.,
2004) on the other. However, in spite of decades of research
aimed at understanding its neurobiological basis, drug addiction
represents a complex pathological condition for which a still
limited list of therapeutic tools, restricted mostly to opioids,
nicotine and alcohol dependence, is available (Lyon, 2017).
Hence, the preclinical search of new therapeutic approaches,
including the application and development of strategies based
on the use of substances obtained from herbal remedies or
from whole herbal extracts (Carai et al., 2000; Lu et al., 2009;
Liu et al., 2011; Zhang et al., 2014), appears nowadays highly
desirable. In this regard, the standardized methanolic extract
of WS roots (WSE) has recently been shown to affect the
ability of morphine (Ruiu et al., 2013) and ethanol (Spina
et al., 2015) to elicit acquisition and expression of conditioned
place preference (CPP) in mice as well as the acquisition and
maintenance of oral ethanol self-administration in rats (Peana
et al., 2014). However, in spite of the behavioral evidence
gathered on the efficacy of WSE to significantly reduce the
affective and motivational impact of the acute administration
of morphine and ethanol, no studies have attempted yet to
clarify the mechanism(s) by which such effects of WSE may
take place. In this regard, one of the most likely candidate
mechanism by which WSE impairs acquisition and expression
of morphine- and ethanol-elicited CPP (Ruiu et al., 2013; Spina
et al., 2015) and acquisition and maintenance of ethanol oral self-
administration (Peana et al., 2014) is represented by the ability
of WSE to affect morphine- and ethanol-elicited increase of the
spontaneous firing rate of VTA DA neurons as well as of phasic
DA transmission in the AcbSh.
Hence, in order to shed light on the mechanism(s) by
which WSE prevents DA-mediated morphine- and ethanol-
elicited motivated behaviors (Ruiu et al., 2013; Peana et al., 2014;
Spina et al., 2015), the present study aimed at characterizing
further the ability of WSE to affect the psychopharmacological
properties of morphine and ethanol by assessing whether it may
also interfere with the ability of these substances to stimulate
VTA DA neuronal firing activity and prevent morphine- and
ethanol-elicited increases of DA transmission in the AcbSh. In
addition, to further characterize the mechanism by which WSE
may affect the firing activity of VTA DA neurons by itself, we also
applied WSE in the presence of GABAA and GABAB receptors
antagonists, bicuculline and SCH50911, respectively. To this end,
ex vivo standard patch-clamp recordings of VTA DA neurons in
mesencephalic slices and in vivo brain microdialysis in the AcbSh,
from male Sprague-Dawley rats, were performed.
MATERIALS AND METHODS
Subjects
Male Sprague-Dawley rats (Envigo, Italy) bred in our animal
facility (19–30 days of age) and male Sprague-Dawley rats
(Envigo, Italy) (45–52 days of age) were used for the
electrophysiological and the microdialysis experiments,
respectively. Animals had access to water and standard laboratory
food (Stefano Morini, S. Polo D’Enza, RE, Italy) ad libitum.
Animal care and handling throughout the experimental
procedures were in accordance with the guidelines for care
and use of experimental animals of the European Community
Council (2010/63/UE L 276 20/10/2010) and with Italian law
(DL 04.03.2014, N◦ 26). In particular, this study was approved by
the Organization for Animal Care of the University of Cagliari
(OPBA-UniCA) and performed in accordance with the Ministry
of Health authorization number 1177/2016-pr (December 15,
2016). Every effort was made to minimize suffering and reduce
the number of animals used.
Experimental Procedures for
Electrophysiological Experiments
Preparation of Rat VTA Slices
Brain slices were prepared as previously described by Talani et al.
(2011, 2016). In brief, at post-natal day (PND) 19–30, animals
were subjected to 5% isoflurane deep anesthesia and decapitated.
Brains were rapidly removed from the skull and transferred into a
modified artificial cerebrospinal fluid (aCSF) solution containing
(in mM): 220 sucrose, 2 KCl, 0.2 CaCl2, 6 MgSO4, 26 NaHCO3,
1.3 NaH2PO4, and 10 D-glucose (pH 7.4, set by aeration with
95% O2 and 5% CO2). Horizontal brain slices containing the
VTA (thickness, 260 µm) were cut in ice-cold modified aCSF
with the use of a Leica VT1200S vibratome (Leica, Heidelberg,
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Germany). The slices were then transferred immediately to a
nylon net submerged in standard aCSF containing (in mM): 126
NaCl, 3 KCl, 2 CaCl2, 1 MgCl2, 26 NaHCO3, 1.25 NaH2PO4,
and 10 D-glucose (pH 7.4, set by aeration with 95% O2 and 5%
CO2). After an incubation for at least 40 min at the controlled
temperature of 35◦C and a subsequent waiting for at least
1 h at room temperature, hemi-slices were transferred to the
recording chamber and continuously perfused with standard
aCSF at a constant flow rate of ∼2 ml/min. For all recordings,
the temperature of the bath was maintained at 33◦C.
Patch-Clamp Recordings
Patch-clamp recordings from VTA dopaminergic neurons were
performed as previously described by Dazzi et al. (2014).
Recording pipettes were prepared from borosilicate capillaries
with an internal filament with the use of a P-97 Flaming
Brown micropipette puller (Sutter Instruments, Novato, CA,
United States). Resistance of the pipettes ranged from 4.5 to
6.0 M when they were filled with the following solution
(in mM): 135 potassium gluconate, 10 MgCl2, 0.1 CaCl2, 1
EGTA, 10 Hepes-KOH (pH 7.3), and 2 ATP (disodium salt).
Signals were recorded with the use of an Axopatch 200-B
amplifier (Axon Instruments Inc., San Jose, CA, United States),
filtered at 2 kHz, and digitized at 5 kHz. The pClamp 9.2
software (Molecular Devices, Union City, CA, United States)
was used in order to measure and analyze the firing rate and
other membrane kinetic parameters of VTA neurons as well
as the occurrence of HCN-mediated Ih currents (see below).
The cell-attached configuration was used for monitoring the
spontaneous firing rate in control condition (baseline) as well
as during and after drug application. After obtaining a pipette-
membrane seal with a G resistance, at least 10 min were
allowed prior recording, in order to have a stable and regular
baseline firing rate. At the end of each recording, the whole-
cell configuration was obtained to determine the presence of
Ih currents, in order to confirm the identity of VTA DA
neurons. In fact, as also previously reported by Grace and
Onn (1989), in the present experiments DA neurons in the
VTA were identified by the presence of both an Ih current
(mean amplitude: −185 ± 43 pA, n = 40) evoked in response
to a single hyperpolarizing voltage step, from −65 to −115
mV, and a regular firing rate of spontaneous action potentials
(4.84± 0.4 Hz, n = 40).
Experimental Procedures for
Microdialysis Experiments
Surgery
Beginning 3 days before surgery, rats were handled once daily
for 5 min to habituate them to the contact with the operator
and to the experimental procedures (intraperitoneal and gavage
administrations). Under deep anesthesia by equitesin, as reported
by Bassareo et al. (2015), a vertical microdialysis probe was
stereotaxically and unilaterally implanted in the AcbSh, randomly
in the left or in the right hemisphere, using the following
coordinates: AP: 2.0 mm from bregma, ML: 1 mm from bregma
and DV: −7.6 mm from dura, according to the rat brain atlas
of Paxinos and Watson (1998). After surgery, rats were housed
in individual hemispheric cages under the same standard animal
facility conditions, left undisturbed for at least 24 h and fed
daily with 20 g of standard chow (their weight being maintained
at approximately 95% of their ad libitum weight). Water was
available ad libitum throughout the duration of experiments.
Probe Preparation
Vertical dialysis probes were prepared with AN69 fibers (Hospal
Dasco, Bologna, Italy), according to the method of Di Chiara
et al. (1993) as modified by Tanda et al. (1996). The length of the
dialyzing portion of the probe was 1.5 mm.
Microdialysis Experiments
On the day of the experiment, probes were connected to an
infusion pump and perfused with Ringer’s solution (in mM):
147 NaCl, 4 KCl, 2.2 CaCl2 (see Lecca et al., 2006 on the use of
2.2 mM Ca2+ in the Ringer) at the constant rate of 1 µl/min.
Dialysate samples (10 µl) were taken every 10 min and injected
without purification into either a high-performance liquid
chromatograph (HPLC) or an ultra HPLC (UHPLC; ALEXYS
Neurotransmitter analyzer, Antec, Zoeterwoude, Netherlands).
The HPLC was equipped with a reverse phase column (LC-18
DB, 15 cm, 5 µm particle size, Supelco, Waters, Milford, MA,
United States) and a coulometric detector (ESA, Coulochem
II, Bedford, MA, United States) to quantify DA. The first
electrode of the detector was set at +125 mV (oxidation) and
the second at −175 mV (reduction). The composition of the
mobile phase was (in mM): 50 NaH2PO4, 0.1 Na2-EDTA, 0.5
n-octyl sodium sulfate, 15% (v/v) methanol, pH 5.5 (obtained
by adding Na2HPO4). Under these conditions, sensitivity of the
assay for DA was 5 femto-moles (fmol)/sample. The UHPLC
was equipped with a NeuroSep (C18 110, 1.0 × 100 mm, 1.7
µm) column (Supelco, Waters, Milford, MA, United States) and
an electrochemical amperometric detector (DECADE II SCC)
(Antec, Zoeterwoude, Netherlands). Composition of the mobile
phase was (in mM): 100 phosphoric acid, 100 citric acid, 0.1
EDTA, 8% (v/v) acetonitrile. Using these conditions sensitivity
of the assay for DA was 5 fmol/sample. Every subject was
administered, for pre-treatment (saline or WSE) and treatment
(saline or tap water or morphine or ethanol) only once during
the experimental session.
Histology
At the end of the microdialysis experiment, rats were anesthetized
as reported by Bassareo et al. (2015), probes were removed
and the brains were kept in a 4% (w/v) formaldehyde solution
for at least 1 week and successively cut with a vibratome in
serial coronal slices oriented according to the rat brain atlas
of Paxinos and Watson (1998). The location of the probes was
reconstructed and referred to the rat brain atlas of Paxinos and
Watson (1998) (Figure 1). One rat was excluded from the study
for cannula misplacement.
Drugs and Treatments
For electrophysiological experiments, morphine hydrochloride
(Franchini Prodotti Chimici Srl, Mozzate, Como, Italy) was
dissolved in standard aCSF and bath-applied to brain slices at
the concentration of 10 µM; ethanol (Sigma-Aldrich, Milan,
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FIGURE 1 | Localization of dialysis probes (dialyzing portion) within the
AcbSh. Representative images of the probe location (drawn after histological
examination) in the brain atlas plates showing the AcbSh (sh) at different AP
distances from bregma according to the rat brain atlas of Paxinos and Watson
(1998).
Italy) was diluted in standard aCSF and bath-applied at the
concentration of 80 mM; WSE (the standardized dry methanolic
extract of Withania somnifera roots (Natural Remedies Pvt. Ltd.,
Bangalore, India) whose certificate of analysis reports that solvent
residues were in compliance with the limits envisioned in the
British and US Pharmacopoeias) was dissolved in standard aCSF
and bath-applied to brain slices at concentrations of 40, 100,
200, and 400 µg/ml. WSE, in the absence or presence of either
morphine or ethanol, was bath applied in accordance with the
following protocol: (i) recording of basal firing activity (baseline)
for at least 3–5 min; (ii) perfusion of WSE for 5–15 min; (iii)
wash-out of variable length (usually between 20 and 40 min,
until firing returned to basal control levels); (iv) co-perfusion
of WSE and morphine or ethanol for 5–15 min. In this respect,
both morphine and ethanol were bath-applied twice: the first time
(followed by an appropriate wash-out) after a stable baseline was
recorded and, the second time, 10 min after the beginning of WSE
perfusion. A new baseline was set after WSE induced a stable
inhibitory effect on firing rate, and this was used to calculate the
action of both drugs.
For in vivo microdialysis experiments, morphine
hydrochloride (Franchini Prodotti Chimici Srl, Mozzate,
Como, Italy) was dissolved in physiological saline [0.9% (w/v)
NaCl] and administered subcutaneously (s.c.) at the dose of
5 mg/kg/1 ml; ethanol (Sigma-Aldrich, Milan, Italy), diluted at
the concentration of 20% (v/v) in tap water, was administered
intragastrically (i.g.) at the dose of 1 g/kg/10 ml. WSE (Natural
Remedies Pvt. Ltd., Bangalore, India) was dissolved in saline
and administered intraperitoneally (i.p.) at the doses, 75 or 100
(data not shown) mg/kg, selected on the basis of our previous
studies (Kasture et al., 2009; Ruiu et al., 2013; Peana et al., 2014;
Spina et al., 2015). Randomization of animals was made before
starting the in vivo experiments. Animals were randomized in
two different experimental groups, treated with saline or WSE.
WSE was administered 30 min before morphine treatment, as
reported by Ruiu et al. (2013) and Orrù et al. (2014) and 60 min
before ethanol treatment, as reported by Spina et al. (2015).
Moreover, in order to have WSE administered 60 min before
(hence, to adopt the same experimental conditions for ethanol
and morphine data), we also performed a set of experiments
administering WSE 60 min before the morphine treatment.
The composition of the standardized methanolic extract of
Withania somnifera roots (i.e., different batches have similar,
and certified, composition with respect to the total withanolides’
content) on the basis of HPLC analysis, as certified by
Natural Remedies Pvt. Ltd., Bangalore, India, was as follows:
Withanoside-IV: 0.49% (w/w); Physagulin D: 0.11% (w/w); 27-
Hydroxywithanone: 0.01% (w/w); Withanoside-V: 0.33% (w/w);
Withaferin-A: 0.11% (w/w); 12-Deoxywithastramonolide: 0.16%
(w/w); Withanolide-A: 0.19% (w/w); Withanone: 0.004% (w/w);
and Withanolide-B: 0.03% (w/w) (Kasture et al., 2009).
Statistics
For the electrophysiological experiments, statistical analysis was
performed with one-way analysis of variance (ANOVA), followed
by Bonferroni’s post hoc test with statistical significance set
at P < 0.05 using Prism 6.0 software (GraphPad Software,
La Jolla, CA, United States). The statistical analysis for
the microdialysis experiments was carried out by Statistica
8.0 (StatsSoft Inc., Tulsa, OK, United States) for Windows.
Basal dialysate DA was calculated as the mean of the last
three consecutive samples differing by no more than 10%,
collected during the time period preceding each treatment.
Basal dialysate DA values, expressed as fmol/10 µl of dialysate,
were compared between groups by one-way ANOVAs. Changes
in dialysate DA were expressed as percent of the respective
baseline values and were analyzed by two-way ANOVAs with
repeated measures over time. Results from treatments showing
significant overall changes were subjected to post hoc Tukey’s
test with statistical significance set at P < 0.05. Sample size
was defined as “n” and clearly indicated for every graph
in figures. Due to the type of experiments conducted no
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blinding approach was made. The number of animal to be
used for the experiments was obtained “a priori” through
GPower software.
RESULTS
Electrophysiological Experiments
Effect of WSE on Spontaneous and Morphine- and
Ethanol-Induced Increase in Firing Rate of VTA DA
Neurons
Identification of single VTA DA neurons was confirmed
by the presence of HCN-mediated Ih currents, evoked by
hyperpolarizing the cell membrane from −65 to 115 mV
(amplitude, −185 ± 43 pA; n = 40) (data not shown), and
of a regular spontaneous firing rate (4.84 ± 0.4 Hz, n = 40)
(Figure 2A, control) (Ungless and Grace, 2012) In addition, the
stimulatory effect induced by the GABAB receptor antagonist
SCH 50911 (10 µM) (Figure 2G) on firing rate further proved
the dopaminergic phenotype of the recorded VTA neurons
(Margolis et al., 2012). In order to evaluate quantitatively the
effects of WSE, alone or in combination with morphine or
ethanol, on the spontaneous firing activity of DA neurons
in rat VTA slices, spike discharge was recorded in the cell-
attached configuration. When applied alone, WSE (40–400
µg/ml) significantly decreased the firing rate of VTA DA
neurons in a concentration-dependent manner [F(4,74) = 10.24,
P < 0.0001] (Figures 2A–C). A representative effect of WSE (200
µg/ml) is depicted in Figure 2A, whereas Figure 2B illustrates
the time-course of the action of WSE recorded in a single DA
neuron. The apparent threshold concentration of WSE that was
effective in altering DA neuron firing ranged between 100 and 200
µg/ml (Figure 2C). At the highest tested concentrations of 200 or
400 µg/ml, the action of WSE resulted in a significant decrease
of neuron firing of 37.3 ± 8.1% (P < 0.001) and 37.3 ± 5.5%
(P < 0.001), respectively, compared to baseline.
In order to elucidate the possible mechanism of action through
which WSE may mediate its inhibitory effect on firing rate of
VTA neurons, we perfused WSE (200 µg/ml) in the presence of
GABAA and GABAB receptor selective antagonists, bicuculline
(20 µM) and SCH 50911 (10 µM), respectively. As shown
in Figures 2D,E, in the presence of bicuculline WSE failed
to reduce the firing rate of VTA dopaminergic neurons. It is
noteworthy that 3-min perfusion of bicuculline alone elicited a
slight but significant increase of the firing rate that may likely
depend on the suppression of the GABAA-mediated inhibitory
input onto DA cells (Figures 2D,E). On the contrary, WSE still
decreased the firing rate of VTA neurons in the presence of
the GABAB selective antagonist SCH 50911. The perfusion of
SCH 50911 alone produced a significant increase of the firing
rate (Figures 2F,G), consistent with the selective postsynaptic
expression of GABAB receptors on VTA dopaminergic neurons
(Margolis et al., 2012).
As expected from previous reports (Gysling and Wang, 1983;
Laviolette et al., 2004; Chen et al., 2015; Melis et al., 2015),
morphine (10 µM) significantly enhanced the spontaneous firing
rate of VTA DA neurons by 96.7 ± 12.8% (P < 0.0001 vs.
baseline) (Figures 3A–C). Notably, this effect was prevented
(P < 0.05) in the presence of the highest concentration
(400 µg/ml) of WSE, whereas lower concentrations resulted
completely ineffective [F(5,29) = 15.96, P < 0.001] (Figure 3C).
As previously reported (Brodie et al., 1990; Brodie and Appel,
1998; Xiao and Ye, 2008; Xiao et al., 2009), bath-perfusion
with ethanol (80 mM) produced a significant increase of DA
neuronal firing rate (38.6 ± 6.8%, P < 0.05 vs. baseline)
(Figures 4A–C). When each of the different concentrations of
WSE (40, 100, 200, or 400 µg/ml) was bath-applied for 10 min
prior to the co-perfusion with ethanol (80 mM), its stimulatory
effect was reduced to 13.2 ± 8.4% by WSE at 100 µg/ml, and
completely suppressed by WSE at 200 and 400 µg/ml (P > 0.05)
(Figures 4B,C).
Brain Microdialysis Experiments
Basal AcbSh DA concentration (fmol/sample, mean ± SEM) was
on average 55± 3 (n = 56) and baseline DA did not differ between
treatment groups [F(12,43) = 0.003; P > 0.05].
Effect of WSE Administration on Morphine- and
Ethanol-Elicited Increase of DA Transmission in the
AcbSh
Figure 5 shows the effects of saline or WSE (75 mg/kg)
administration followed, 30 min later, by the administration of
saline (Figure 5A) (N = 8) or morphine (5 mg/kg) (Figure 5B)
(N = 8) on AcbSh DA transmission.
Saline or WSE administration failed to significantly affect
basal DA. Two-way ANOVA of data obtained after saline
or WSE administration and restricted to the 30 min before
saline or morphine administration, revealed a significant effect
of time [F(3,30) = 16.72; P < 0.001] but not of treatment
[F(3,10) = 0.60, P = 0.63] nor a significant treatment × time
interaction [F(9,30) = 0.39, P = 0.93]. However, post hoc test
failed to reveal any significant DA change after saline or WSE,
nor difference between groups.
In agreement with previous reports, morphine significantly
increased AcbSh DA transmission and WSE administration
significantly prevented this increase. Two-way ANOVA of data
obtained after saline or morphine administration to saline-
or WSE- pre-treated rats revealed significant effects of time
[F(24,240) = 8.51, P < 0.001] and treatment [F(3,10) = 12.87,
P < 0.01] and a significant treatment × time interaction
[F(72,240) = 4.07, P < 0.001]. Post hoc test revealed that
morphine significantly increased DA transmission in the AcbSh
and that this increase was significantly reduced by WSE pre-
treatment.
Similarly to the experiments in which WSE was administered
30 min before saline or morphine, we found that saline or
WSE administration failed to significantly affect basal DA.
Two-way ANOVA of data obtained after saline or WSE
administration and restricted to the 60 min before saline or
morphine administration, revealed a significant effect of time
[F(6,84) = 3.67; P < 0.01] but not of treatment [F(3,14) = 1.42,
P = 0.28] nor a significant treatment × time interaction
[F(18,84) = 1.56, P = 0.09]. Post hoc test failed to reveal
significant DA changes after saline or WSE and significant
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FIGURE 2 | Effect of WSE on VTA DA neurons firing rate. (A) Representative traces of spontaneous firing recorded in the cell-attached configuration from a single
DA neuron before (a: baseline), during (b) and after (c: wash-out) bath-application of WSE (200 µg/ml). Scale bar: 1 s. (B) The graph shows the temporal changes of
firing rate of a single VTA DA neuron before (a: baseline), during (b) and after (c: wash-out) bath-application of WSE (200 µg/ml). Values are expressed as percent
change from baseline. Points and letters indicate the correspondent section of the trace that was isolated from the whole recording and reported in panel (A).
(C) The graph reports the concentration-dependent effect of WSE on firing rate recorded in VTA DA neurons. Data are expressed as percent change from baseline
(Continued)
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FIGURE 2 | Continued
and are means ± SEM (n = 5–32 cells from 10 animals). ∗∗P < 0.01 vs. baseline. (D) The graph shows the temporal changes of firing rate of a single VTA DA neuron
during and after (wash-out) bath-application of WSE (200 µg/ml) in the presence of the GABAA antagonist bicuculline (bic) 20 µM. Values are expressed as percent
change from baseline. (E) Bar graph reports the average of different recorded cells (n = 5 cells from three animals) in which the effect of bicuculline and co-perfusion
of bicuculline and WSE was evaluated. Data are expressed as percent change from baseline and are means ± SEM. ∗P < 0.05 vs. baseline. (F) The histogram
graph shows the temporal changes of firing rate of a single VTA DA neuron during and after (wash-out) bath-application of WSE (200 µg/ml) in the presence of the
GABAB antagonist SCH 50911 10 µM. Values are expressed as percent change from baseline. (G) The histogram graph reports the average of different recorded
cells (n = 5 cells from three animals) in which the effect of SCH 50911(sch) and co-perfusion of SCH 50911 and WSE was evaluated. Data are expressed as percent
change from baseline and are means ± SEM. ∗P < 0.05 vs. baseline.
FIGURE 3 | Effects of WSE on the stimulatory action of morphine on VTA DA neuron firing rate. (A) Representative traces of spontaneous firing recorded form a
single DA neuron before (baseline), during and after (wash-out) the bath-application of morphine (10 µM) alone and in the presence of WSE (400 µg/ml). Scale bar: 1
s. (B) The graph shows the temporal changes of firing rate of a single VTA DA neuron during and after (wash-out) bath-application of morphine (10 µM) (Mor) alone
and of morphine in the presence of WSE (400 µg/ml). Values are expressed as percent change from baseline. Points and letters indicate the correspondent section
of the trace that was isolated from the whole recording and reported in panel (A). (C) The histogram graph shows the concentration–response effect of WSE on the
stimulatory action of morphine on firing rate. Data are expressed as percent change from baseline and are means ± SEM. The number of cells analyzed (obtained
from at least three animals per group of recordings) is indicated by the number inside each histogram. ∗∗∗P < 0.0001 vs. baseline; #P < 0.05 vs. morphine alone.
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FIGURE 4 | Effects of WSE on the stimulatory action of Ethanol on VTA DA neuron firing rate. (A) Representative traces of spontaneous firing recorded from a single
DA neuron before (baseline), during and after (wash-out) the bath-application of ethanol (80 mM) (EtOH) alone and in the presence of WSE (200 µg/ml). Scale bar:
1 s. (B) The graph shows the temporal changes of firing rate of a single VTA DA neuron during and after (wash-out) bath-application of EtOH (80 mM) alone and of
EtOH in the presence of WSE (200 µg/ml). Values are expressed as percent change from baseline. Points and letters indicate the correspondent section of the trace
that was isolated from the whole recording and reported in panel (A). (C) The histogram graph shows the concentration–response effect of WSE on the stimulatory
action of ethanol on firing rate. Data are expressed as percent change from baseline and are means ± SEM. The number of cells analyzed (obtained from at least
three animal per group of recordings) is indicated by the number inside each histogram. ∗P < 0.05 vs. baseline; #P < 0.05 vs. ethanol alone.
differences between groups. Moreover, as in the experiments
depicted in Figure 5, morphine (administered 60 min after
saline) significantly increased AcbSh DA transmission and WSE
administration (60 min before morphine) significantly prevented
this increase. Two-way ANOVA of data obtained after saline
or morphine administration to saline- or WSE- pre-treated rats
revealed significant effects of time [F(24,336) = 12.28, P < 0.01]
and treatment [F(3,14) = 11.36, P < 0.01] and a significant
treatment × time interaction [F(72,336) = 4.95, P < 0.01].
Post hoc test revealed that morphine significantly increased DA
transmission in the AcbSh and that this increase was significantly
prevented by WSE pre-treatment (data not shown).
Figure 6 shows the effects of saline or WSE (75 mg/kg)
administration followed, 60 min later, by the administration of
water (Figure 6A) (N = 8) or ethanol (1 g/kg) (Figure 6B)
(N = 11) on AcbSh DA transmission.
Saline orWSE administration failed to significantly affect basal
DA. Two-way ANOVA of data obtained after saline or WSE
administration and restricted to the 60 min before water or
ethanol administration, failed to reveal significant effects of time
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FIGURE 5 | Effects of WSE (30 min beforehand) on basal and morphine-
elicited stimulation of DA transmission in the AcbSh. (A) AcbSh DA
responsiveness to saline or WSE administration. (B) Effect of saline (s.c.) or
morphine (5 mg/Kg s.c.) administration on DA transmission in the AcbSh of
saline- or WSE- pre-treated, 30 min beforehand, rats. Data are means ± SEM
of the results, expressed as a percentage of basal values. Filled symbols
(•/) indicate P < 0.05 vs. basal values; ∗ indicates P < 0.05 with respect to
WSE + morphine; + indicates P < 0.05 with respect to WSE + saline;
x indicates P < 0.05 with respect to saline + saline.
[F(6,84) = 1.95; P< 0.08] and treatment [F(3,14) = 0.15, P = 1.95]
and significant treatment × time interaction [F(6,84) = 0.63,
P = 0.86]. Accordingly, post hoc test failed to reveal any
significant DA change after saline or WSE and significant
differences between groups.
In agreement with previous reports, ethanol significantly
increased AcbSh DA transmission and WSE administration
prevented this increase. Two-way ANOVA of data obtained after
water or ethanol administration to saline- or WSE-pre-treated
rats revealed significant effects of time [F(20,28) = 1.75, P< 0.03]
and treatment [F(3,14) = 23.10, P < 0.001] and a significant
treatment × time interaction [F(20,28) = 1.79, P < 0.001].
Post hoc test revealed that ethanol significantly increased DA
transmission in the AcbSh and that this increase was significantly
prevented by WSE pre-treatment.
FIGURE 6 | Effects of WSE (60 min beforehand) on basal and ethanol-elicited
stimulation of DA transmission in the AcbSh. (A) AcbSh DA responsiveness to
saline or WSE administration. (B) Effect of tap water (H2O) (i.g.) or ethanol
(EtOH) (1 g/Kg i.g.) administration on DA transmission in the AcbSh of saline-
or WSE- pre-treated rats, 60 min beforehand. Data are means ± SEM of the
results, expressed as a percentage of basal values. Filled symbols (•/)
indicate P < 0.05 vs. basal values; ∗ indicates P < 0.05 with respect to
WSE + EtOH; + indicates P < 0.05 with respect to WSE + H2O; x indicates
P < 0.05 with respect to saline + H2O.
DISCUSSION
Previous studies demonstrated that the acute administration of
the standardized methanolic extract of WS roots prevents the
acquisition and expression of morphine- and ethanol-elicited
motivated behaviors in CPP experiments (Ruiu et al., 2013;
Spina et al., 2015) as well as the acquisition and maintenance
of oral ethanol self-administration (Peana et al., 2014) but,
to date, no experimental evidence has been provided to the
mechanistic interpretation of these findings. Therefore, the
present study was aimed at evaluating the possibility that
such behavioral effects of WSE could be based on its ability
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to affect morphine- and ethanol-stimulated firing activity of
VTA DA neurons and DA transmission in the AcbSh. To
this end, this study firstly evaluates whether WSE would
affect the spontaneous firing of VTA DA neurons and the
associated basal DA transmission in efferent areas such the
AcbSh. The electrophysiological data indicate, for the first time,
that bath application of WSE to mesencephalic slices of rats,
reversibly and concentration-dependently, negatively modulates
the spontaneous firing rate of DA neurons in the VTA. In
particular, we found that perfusion of VTA slices with WSE
resulted in a significant and reversible decrease in firing rate of
DA neurons at concentrations of 200 µg/ml and above, an effect
that could be blocked in the presence of the GABAA selective
receptor antagonist, bicuculline. Secondly, in agreement with
previous extensive literature, the study describes that morphine
and ethanol consistently increased both the firing rate of DA
neurons in the VTA (Gysling and Wang, 1983; Brodie et al.,
1990; Brodie and Appel, 1998; Laviolette et al., 2004; Xiao
and Ye, 2008; Xiao et al., 2009; Melis et al., 2015) and DA
transmission in the AcbSh (Imperato and Di Chiara, 1986; Di
Chiara and Imperato, 1988; Bassareo et al., 2003). In particular,
as far as the effect of ethanol on firing rate is concerned, we
acknowledge that the concentration used (80 mM) could be
considered fairly high but, as previously discussed by us (Melis
et al., 2015), it may be misleading to make direct comparisons
between concentrations (between 20 and 40 mM) attainable
upon systemic administration of doses in the range between 1
and 2 g/kg, those achieved upon intra VTA self-administration
(between 17 and 66 mM) (Rodd et al., 2005) and, finally, those
used in ex vivo preparations (in the range between 80 and
100 mM) (Melis et al., 2015 and present data). In addition,
in previous studies in which the effects of ethanol on VTA
DA neuron firing rate were analyzed (see Brodie et al., 1990;
Brodie and Appel, 1998) concentrations of ethanol ranging from
40 to 160 mM were used. The concentration of 80 mM was
chosen as it provides a reliable and reproducible effect in our
experimental conditions.
Thirdly, the main findings of the present study disclose that
WSE significantly attenuates the ability of both morphine and
ethanol to stimulate spontaneous firing of DA neurons in the
VTA and DA transmission in the AcbSh.
The pattern of firing activity of mesencephalic DA neurons
varies between low-frequency “tonic” firing activity and brief
higher frequency “phasic” bursts of action potentials (Grace
and Bunney, 1984), but see for review Rice et al. (2011), and
spontaneous firing of DA neurons in the VTA and DA release
and transmission in the AcbSh are correlated. However, while
the transition from “tonic” to “phasic” activity of DA neurons
is correlated with a discrete and marked increase in DA release
and DA signaling in the AcbSh (Grace, 1995; Sombers et al.,
2009), alterations (decrease or increase) in low-frequency tonic
firing activity are not always tightly correlated with parallel
changes in AcbSh DA signaling (Hollerman et al., 1992; Grace,
1995). A number of modulatory systems and neurotransmitters
in the AcbSh contribute to regulate DA release, including
glutamate, GABA, and acetylcholine (Rice et al., 2011). Thus,
based on these observations, our data showing that WSE, at
the concentration of 200 µg/ml and above, reduced basal low-
frequency firing activity of VTA DA neurons but did not
alter basal DA transmission in the AcbSh, neither at the dose
of 75 mg/kg (Figures 5, 6) nor at 100 mg/ml (data not
shown), should not be surprising. In addition, we should also
consider the obvious difference in the two experimental models
used which may imply circuit effects in the intact organism
that are not present in the ex vivo preparation. In addition,
we might also hypothesize that some WSE components that
contribute to the effect detected in the ex vivo experimental
setting may, upon systemic administration, not cross the blood–
brain barrier (BBB). Moreover, as it has been shown in other
cases in which the effects of a given compound (for instance
salsolinol) on DA transmission in the AcbSh were opposite
depending on the site of its application [VTA: increase (Deehan
et al., 2013); AcbSh: decrease (Hipólito et al., 2009)], it is
also plausible that, after its systemic administration, WSE may
have reached a non-pharmacologically significant concentration
within the AcbSh (or virtually any other related area) to
exert a local (intra-AcbSh?) action responsible of the lack
of effect herewith highlighted by microdialysis experiments.
Thus, although at this stage we cannot offer any conclusive
demonstration of the mechanism behind this observation, we
suggest that both factors, ex vivo vs. intact experimental models
and crossing vs. not crossing the BBB, may be relevant for
its most plausible interpretation. Local microinjection of WSE
into discrete brain areas may help to address this issue in
a further study.
The observation that WSE, bath co-perfused with morphine
or ethanol, could significantly prevent their ability to stimulate
the spontaneous firing in VTA slices at different concentrations
(in the case of morphine, 400 µg/ml, that is two to four times
higher than those required on ethanol-elicited neuronal firing),
indicates that the mechanism by which WSE affects this property
of morphine is less sensitive than that at the basis of the ability
of ethanol to stimulate DA neuronal firing. In this regard it is
critical to point out that the perfusion with morphine or ethanol
was accomplished in the presence of WSE and therefore in the
condition of inhibition of spontaneous firing. In particular, co-
perfusion of WSE with morphine or ethanol was performed at the
end of a wash-out period that was required to allow morphine- or
ethanol-elicited increase of spontaneous firing to recover back to
basal (control) levels (as shown in Figures 3B, 4B). Therefore,
the effects of WSE and those of morphine or ethanol (Brodie
et al., 1990; Brodie and Appel, 1998; Xiao and Ye, 2008; Xiao
et al., 2009; Chen et al., 2015) should be considered as functionally
antagonistic on the stimulation of neuronal firing in the VTA.
In the present study, we also performed specific experiments
in order to address the potential molecular mechanism(s)
underlying this antagonism. Our results showing that the
inhibitory effect of WSE on spontaneous firing of VTA DA
neurons was completely abolished by the GABAA, but not
GABAB, receptor selective antagonist bicuculline, suggest that
GABAA receptors may be directly involved in this action of
WSE on VTA DA neurons. This finding appears in agreement
with other reports showing that GABAA receptors are sensitive
targets of WSE in different brain regions (Bhattarai et al.,
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2010; Yin et al., 2013; Candelario et al., 2015). Such results
also appear in line with previous receptor binding studies
demonstrating that WSE shows high to moderate affinities,
ki values being 13 and 130 µg/ml for GABAA and GABAB
receptors, respectively (Ruiu et al., 2013; Orrù et al., 2014).
Thus, on the basis of our previous receptor binding studies
(Ruiu et al., 2013; Orrù et al., 2014), at the present stage
of our investigations on the ability of WSE to affect the
motivational properties of addictive drugs (Ruiu et al., 2013;
Orrù et al., 2014; Spina et al., 2015) we can only hypothesize
the involvement of GABAA but not GABAB receptor subtypes
in the VTA. Moreover, the possibility that WSE might prevent
the effects of morphine and ethanol on spontaneous firing
through the involvement of DA and opioid receptors should
be discarded due to the low affinities of the whole WS roots
extract for these receptors (Ruiu et al., 2013; Orrù et al., 2014).
In further support of the involvement of GABAA receptors in
the pharmacological effects of WSE it was shown that WSE
activates GABAA receptors-mediated Cl− currents (Bhattarai
et al., 2010; Yin et al., 2013; Candelario et al., 2015) and
that ashwagandha (Withania somnifera) (50–200 mg/kg p.o.)
makes animals less seizure-prone by exhibiting dose-dependent
anticonvulsant effects [i.e., enhances pentylenetetrazol (PTZ)-
induced seizure threshold] in mice (Akula et al., 2009), an
interpretation further strengthened by our recent identification
into WSE of docosanyl ferulate as a compound able to enhance
GABAA inhibitory postsynaptic currents with an IC50 of 7.9 µM
(Sonar et al., 2019). Altogether, these results encourage to suggest
that WSE may antagonize the increase in VTA firing rate induced
by both morphine and ethanol by facilitating the function of
GABAA, but not GABAB, receptors located post-synaptically
onto the dopaminergic neurons.
On the other hand, our previous work found evidence that
the systemic administration of the GABAB receptor antagonist
phaclofen prevented the ability of WSE to impair maintenance
of oral ethanol self-administration (Peana et al., 2014) suggesting
also an involvement of GABAB receptors in these WSE effects.
We can speculate that such GABAB receptor-mediated action of
WSE might occur not in the VTA but possibly in the AcbSh where
these receptors are expressed in DA fibers (Charara et al., 2000)
and whereby their activation decreases DA release (Schmitz et al.,
2002; Pitman et al., 2014).
In summary, we speculate that the increased VTA DA neuron
firing rate produced in response to both morphine and ethanol
may involve a decreased inhibitory GABAergic tone in these cells
and that morphine is more effective than ethanol, at least at the
concentrations used in the present study. Hence, considering
that the antagonism of WSE toward the effect of both drugs
may be related with its possible potentiation of the GABAergic
system, the different inhibition curve of WSE on the effect of
morphine might be explained by the higher stimulation on the
firing rate by morphine, and higher inhibition of GABAergic
signaling by WSE.
Intriguingly, although not addressed in the present study, at
least as far as the effects of WSE on morphine are concerned,
another plausible interpretation of the ability of WSE to obstruct
(functionally antagonize) the stimulatory properties of morphine
on DA VTA neurons and DA transmission in the AcbSh,
may originate from the observation that WSE, similarly to the
peroxisome proliferator-activated receptors γ (PPARγ) agonist,
pioglitazone (Caputi et al., 2018), has recently been reported
to reduce heroin-induced excitation of VTA DA neurons by
reducing presynaptic GABA release from the rostromedial
tegmental nucleus (De Guglielmo et al., 2015) through the
inhibition of nuclear factor-k B (NF-kB).
In our previous studies, we found that the administration of
WSE could prevent both the acquisition and the expression of
morphine- (Ruiu et al., 2013) and ethanol- (Spina et al., 2015)
elicited CPP. This is particularly intriguing since the ability of
WSE to interfere with both phases of the place conditioning
paradigm allows to speculate on a further psychopharmacological
aspect of the ability of WSE to affect morphine’s and ethanol’s
motivational properties. In fact, the ability of preventing the
acquisition of morphine- and ethanol-elicited CPP (Ruiu et al.,
2013; Spina et al., 2015), but also that of ethanol-elicited
conditioned place aversion (CPA) (Spina et al., 2015), points
to WSE as an agent capable of interfering with the direct
pharmacological action of morphine and ethanol, i.e., to interfere
with the activated biochemical pathway(s) responsible of the
behavioral outcome. In other words, WSE’s ability to prevent
acquisition of drug-elicited place conditioning (either CPP and
CPA) seems to suggest its ability to prevent such distinct
behavioral outcomes by acting in close proximity of a common
mechanism at the basis of the stimulus-stimulus association. In
fact, the ability of stimulating DA transmission preferentially
(and repeatedly) in the AcbSh, after non-contingent (passive)
and contingent exposure (Pontieri et al., 1995, 1996; Tanda
et al., 1997; Bassareo et al., 2003; Lecca et al., 2006, 2007a,b;
Acquas et al., 2007; Aragona et al., 2008; Bassareo et al., 2017)
is common to all drugs of abuse, independently from their
mechanism of action. Notably, the continuous stimulation of
DA transmission in the AcbSh by drugs of abuse produces an
abnormal strengthening of drug–stimulus associations leading
to an attribution of excessive motivational value to discrete
conditioned stimuli or contexts that become predictive of drug
availability. This abnormal association has been hypothesized to
be one of the mechanisms that underlies the development of drug
addiction (Di Chiara, 1998, 1999; Di Chiara et al., 1999). Hence,
by blocking or reducing the increase of AcbSh DA transmission
elicited by morphine or ethanol WSE might be interfering with
their motivational properties and with their ability to produce
such abnormal associative learning.
On the other hand, the observation that WSE also consistently
prevents the expression, in animals in a drug-free state, of the
acquired drug-elicited place conditioning (either preference and
aversion) calls for a further possible mechanism of action of
WSE in order to interpret its ability to interfere with the effects
of conditioned stimuli on behavior. In this regard, we envision
that WSE may also interfere with the mechanism at the basis of
the ability of conditioned stimuli to elicit increased AcbSh DA
transmission (Acquas and Di Chiara, 1994; Di Chiara, 1998; Di
Chiara et al., 1999; Bassareo et al., 2007; Bassareo et al., 2011)
although we also acknowledge that specific experiments will be
required to address the possibility that WSE’s ability to prevent
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also the expression of drug-elicited CPP and CPA encompasses
its interference with mesolimbic DA function (Acquas and Di
Chiara, 1994; Di Chiara et al., 2004).
CONCLUSION
In conclusion, the present results shed fresh light on the
neurochemical and receptor-mediated mechanism(s) at the basis
of the ability of WSE to significantly impact on morphine-
and ethanol-elicited motivated behaviors and further support
the suggestion of a potential therapeutic application of this
extract in drug-contingently and non-contingently motivated
behavioral alterations.
CONTRIBUTION TO THE FIELD
STATEMENT
The abuse of addictive substances is a worldwide problem that
carries a huge burden to public health. A common characteristic
of the central effects of addictive drugs resides in their ability
to stimulate the mesolimbic dopaminergic pathway responsible
of motivated behaviors. Understanding the mechanisms through
which addictive drugs may act in the brain, hijacking the
physiological processes that regulate motivated behaviors still
represents one of the main targets in the neuroscience field.
Accordingly, also the discovery of agents able to antagonize, at
different levels, such hijacking processes is a very challenging
target. In line with the trend of the last decades by which
some natural compounds have proven their efficacy in affecting
the central effects of addictive drugs, the findings of the
present study reveal that a standardized extract of Withania
somnifera (Indian ginseng), is able to prevent the ability of
morphine and ethanol to increase the activity of dopaminergic
neurons by significantly preventing the stimulation neuronal
activity and of neurotransmitter release in terminal regions
of mesolimbic pathway. Thus, together with previous findings
showing that Withania somnifera blocks morphine- and ethanol-
elicited motivated behaviors, the present results provide a
mechanism of these behavioral actions and further point to
this extract as a powerful tool to prevent the acute effects of
morphine and ethanol.
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